Although the EU is thought of as a single market, the conditions for pharmaceutical distribution are complex and varied. There are 27 member states, 30 government healthcare authorities and 23 languages. Stravencon prepares a comprehensive, customised market entry strategy for each Chinese partner, including product patent expiries, the competitive landscape, distribution, pricing and reimbursement schemes.
Working with EU Distribution Partners to Access Markets
Stravencon holds the required licenses and permits for importation and distribution throughout the EU. It also selects and contracts with distributors with the size and reputation to penetrate diverse markets.
Managing the Supply Chain
Logistics and inventory management of pharmaceutical products is critical and complex due to shelf-life and storage requirements. Stravencon chooses the most experienced and competitive logistics partners so that products are collected from Chinese manufacturing sites and delivered to healthcare outlets with complete product integrity.